Navigation Links
SynCardia Introduces New 12-lb Freedom Discharge Driver ,Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
Date:4/22/2009

Latest Generation of Driver Technology to Power Artificial Heart Presented at ISHLT in Paris

Tucson, Ariz. (Vocus) April 22, 2009 -- On April 22-25, SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, introduced the new 12-lb Freedom™ discharge driver at the International Society for Heart and Lung Transplantation (ISHLT) meeting in Paris.

The small, light and “wearable” Freedom driver is designed to provide stable SynCardia Total Artificial Heart patients with a quality “lifestyle” outside the hospital while they wait for a matching donor heart. The Freedom driver is designed to allow patients to live at home, spend time with their family and friends, shop, travel, dine out, attend sporting events, vacation and even return to work.

“The Freedom driver is the next generation in pneumatic driver technology for powering the Total Artificial Heart outside the hospital,” said Rodger Ford, CEO and president of SynCardia. “Our experience discharging stable patients in Europe using our CE approved portable driver has demonstrated that Total Artificial Heart patients can enjoy an active lifestyle at home and in their communities.”

Currently in the U.S., stable Total Artificial Heart patients cannot be discharged. These patients – who are otherwise healthy – must spend weeks, often months trapped in the hospital while they wait for a donor heart. Life for a stable Total Artificial Heart patient confined to the hospital is emotionally, physically and financially draining for them, their family and the hospital.

When the Freedom driver is approved for an FDA / Investigational Device Exemption (IDE) clinical study, stable Total Artificial Heart patients will be discharged from the hospital for the first time in the U.S. Discharge improves quality of life while eliminating most in-hospital costs for this portion of their care.

In Q2 2009, SynCardia plans to submit applications for CE approval of the Freedom driver in Europe and to the FDA to conduct an IDE clinical study of the Freedom driver in the U.S.

Caution– The Freedom™ driver is an investigational device, limited by United States and EU law to investigational use.

Originally designed as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end stage biventricular failure.

The SynCardia Total Artificial Heart is the first and only FDA, Health Canada and CE approved Total Artificial Heart in the world. There have been more than 780 implants of the Total Artificial Heart, accounting for more than 150 patient years of life on the device.

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2348434.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. The ASDS Introduces the First At-Home Skin Cancer Exam Kit
2. AMD LASERS(TM) Introduces the Picasso Diode Laser
3. Amoena Introduces First Post Surgical Garments With Vitamin E & Aloe to Help Soothe and Comfort After Breast Surgery
4. Blue Cross and Blue Shield of Florida Introduces BlueMedicare(SM) Group Supplement
5. Passlogix Introduces Industry's Fastest Sign-On to Kiosks with New Enhancements to v-GO Session Manager
6. Sentillion Introduces Advanced Authentication Solution For Direct Access to Cerner, Eclipsys, Epic, McKesson and MEDITECH Applications
7. Vinpower Digital Introduces Series of Standalone 8X Blu-ray Disc Duplicators with LightScribe Printing Capability
8. Allscripts Introduces SaaS Solution for Prenatal Care
9. Allscripts Introduces Electronic Health Record Capability for iPhone(TM)
10. Covaris Introduces DNA Shearing Service
11. Heavenly Essence Introduces Pureity - the Only Line of Hair Care Products That Really Cares About You
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
SynCardia Introduces New 12-lb Freedom Discharge Driver ,Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
(Date:4/29/2016)... Beach, Calif. (PRWEB) , ... April 29, 2016 , ... ... us. An effective way to confront and deal with these stressors is to adopt ... bad to be good for you. Risa Groux, a certified Holistic Nutritionist and the ...
(Date:4/29/2016)... ... , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd annual “Bite ... a light breeze and temperatures in the 60s. Over 400 runners, walkers and volunteers ... and 1-mile walk were held to increase awareness about Lyme disease and to ...
(Date:4/29/2016)... ... April 29, 2016 , ... Mobility Designed is redefining mobility ... the armpits, the M+D Crutch evenly distributes body weight from the elbow to the ... when using the crutches than with other crutches. , Co-founders Max and Liliana Younger ...
(Date:4/29/2016)... ... 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali ... way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution ... involves one or both jaw bones. This surgery is performed to correct the alignment of ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Regenerative Medicine ... Places to Work employee satisfaction survey, earning them second place for Tampa’s Best Places ... 25-49 employees. , “This is a great accomplishment for our team,” says RMS ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
(Date:4/28/2016)... , April 28, 2016 ... George Phillips und Stephen ...    ArisGlobal®, ein führender Anbieter ... gab heute bekannt, dass neue Führungskräfte zum ... gestoßen sind, die vielfältige Erfahrungen mitbringen.  Dies ...
(Date:4/28/2016)... 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, announced ... 2016 conference, presented by Joseph Gunnar & Co. ... New York . Nadav Kidron , CEO of ... Presentation Details:   PIONEERS 2016, presented ...
Breaking Medicine Technology: